Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04738292Phase 2Terminated
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
ER-positive Breast CancerHER2-negative Breast CancerMetastatic Cancer
StudychairStart date: 2021-10-05

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Medical College of Wisconsin

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kari B Wisinski, MD

University of Wisconsin, Madison

Moderately Similar
3 trials

Shared therapeutic areas:

ER-Positive Breast CancerHER2-negative Breast CancerMetastatic Cancer

Worked with same sponsors:

Context Therapeutics Inc.University of Wisconsin, Madison
Collaborated on 1 trial
Similarity Score34%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

HER2-negative Breast CancerMetastatic Cancer
Similarity Score20%

Shimon Slavin, MD

Hadassah Medical Organization

Related
10 trials

Shared therapeutic areas:

Metastatic Cancer
Similarity Score10%

Naiyer Rizvi, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Metastatic Cancer
Similarity Score10%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Related
13 trials

Shared therapeutic areas:

Metastatic Cancer
Similarity Score10%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Metastatic Cancer
Similarity Score10%

Robert D. Timmerman, MD

Simmons Cancer Center

Related
9 trials

Shared therapeutic areas:

Metastatic Cancer
Similarity Score10%

Shirish M. Gadgeel, MD

Barbara Ann Karmanos Cancer Institute

Related
9 trials

Shared therapeutic areas:

Metastatic Cancer
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic Cancer
Similarity Score10%

Yoshiya Yamada, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Metastatic Cancer
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04738292Phase 2StudyChair

Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

ER-positive Breast CancerHER2-negative Breast CancerMetastatic Cancer
Terminated

All 1 trials loaded